Agilent Technologies Inc (A)

Healthcare | Medical Diagnostics Research
Income Statement (Quarterly) 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Revenue 1,738,000,000 1,668,000,000 1,681,000,000 1,701,000,000
Cost of Revenue 824,000,000 802,000,000 782,000,000 785,000,000
Gross Profit 914,000,000 866,000,000 899,000,000 916,000,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 417,000,000 454,000,000 410,000,000 410,000,000
Operating Expenses 554,000,000 566,000,000 523,000,000 508,000,000
Operating Income 360,000,000 300,000,000 376,000,000 408,000,000
Interest Expense 28,000,000 29,000,000 28,000,000 32,000,000
Income Before Tax 366,000,000 260,000,000 367,000,000 401,000,000
Income Tax Expense 30,000,000 45,000,000 49,000,000 50,000,000
Net Income 336,000,000 215,000,000 318,000,000 351,000,000
Per Share
EPS 1.18 0.75 1.12 1.23
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-10-31 2023-10-31 2022-10-31 2021-10-31 2020-10-31
Revenue 6,510,000,000 6,833,000,000 6,848,000,000 6,319,000,000 5,339,000,000
Cost of Revenue 2,975,000,000 3,368,000,000 3,126,000,000 2,912,000,000 2,502,000,000
Gross Profit 3,535,000,000 3,465,000,000 3,722,000,000 3,407,000,000 2,837,000,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 1,518,000,000 1,634,000,000 1,637,000,000 1,619,000,000 1,496,000,000
Operating Expenses 2,047,000,000 2,115,000,000 2,104,000,000 2,060,000,000 1,991,000,000
Operating Income 1,488,000,000 1,350,000,000 1,618,000,000 1,347,000,000 846,000,000
Interest Expense 96,000,000 95,000,000 84,000,000 81,000,000 78,000,000
Income Before Tax 1,521,000,000 1,339,000,000 1,504,000,000 1,360,000,000 842,000,000
Income Tax Expense 232,000,000 99,000,000 250,000,000 150,000,000 123,000,000
Net Income 1,289,000,000 1,240,000,000 1,254,000,000 1,210,000,000 719,000,000
Per Share
EPS 4.44 4.22 4.19 3.98 2.33
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Assets
Cash and Cash Equivalents 1,329,000,000 1,590,000,000 1,053,000,000 1,484,000,000
Short Term Investments 0 0 0 91,000,000
Net Receivables 1,324,000,000 1,291,000,000 1,405,000,000 1,172,000,000
Inventory 991,000,000 1,031,000,000 1,038,000,000 830,000,000
Total Current Assets 3,959,000,000 4,186,000,000 3,778,000,000 3,799,000,000
Property Plant Equipment 1,955,000,000 1,424,000,000 1,100,000,000 945,000,000
Goodwill and Intangibles 5,021,000,000 4,435,000,000 5,594,000,000 4,956,000,000
Total Assets 11,846,000,000 10,763,000,000 10,516,000,000 10,705,000,000
Liabilities
Account Payables 540,000,000 418,000,000 580,000,000 446,000,000
Short Term Debt 87,000,000 0 36,000,000 0
Total Current Liabilities 1,895,000,000 1,603,000,000 1,861,000,000 1,708,000,000
Long Term Debt 3,487,000,000 2,853,000,000 2,733,000,000 2,729,000,000
Total Liabilities 5,948,000,000 4,918,000,000 5,227,000,000 5,316,000,000
Shareholders Equity
Retained Earnings 750,000,000 782,000,000 324,000,000 348,000,000
Total Shareholders Equity 5,898,000,000 5,845,000,000 5,289,000,000 5,389,000,000
Balance Sheet (Annual) 2024-10-31 2023-10-31 2022-10-31 2021-10-31 2020-10-31
Assets
Cash and Cash Equivalents 1,329,000,000 1,590,000,000 1,053,000,000 1,484,000,000 1,441,000,000
Short Term Investments 0 0 0 91,000,000 158,000,000
Net Receivables 1,324,000,000 1,291,000,000 1,405,000,000 1,172,000,000 1,038,000,000
Inventory 991,000,000 1,031,000,000 1,038,000,000 830,000,000 720,000,000
Total Current Assets 3,959,000,000 4,186,000,000 3,778,000,000 3,799,000,000 3,415,000,000
Property Plant Equipment 1,955,000,000 1,424,000,000 1,100,000,000 945,000,000 845,000,000
Goodwill and Intangibles 5,021,000,000 4,435,000,000 5,594,000,000 4,956,000,000 4,433,000,000
Total Assets 11,846,000,000 10,763,000,000 10,516,000,000 10,705,000,000 9,627,000,000
Liabilities
Account Payables 540,000,000 418,000,000 580,000,000 446,000,000 354,000,000
Short Term Debt 87,000,000 0 36,000,000 0 75,000,000
Total Current Liabilities 1,895,000,000 1,603,000,000 1,861,000,000 1,708,000,000 1,467,000,000
Long Term Debt 3,487,000,000 2,853,000,000 2,733,000,000 2,729,000,000 2,284,000,000
Total Liabilities 5,948,000,000 4,918,000,000 5,227,000,000 5,316,000,000 4,754,000,000
Shareholders Equity
Retained Earnings 750,000,000 782,000,000 324,000,000 348,000,000 81,000,000
Total Shareholders Equity 5,898,000,000 5,845,000,000 5,289,000,000 5,389,000,000 4,873,000,000
Cash Flow Statement (Quarterly) 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Operating Activities
Net Income 1,289,000,000 1,240,000,000 1,254,000,000 1,210,000,000
Depreciation & Amortization 257,000,000 271,000,000 317,000,000 321,000,000
Stock Based Compensation 129,000,000 111,000,000 125,000,000 110,000,000
Change in Working Capital 83,000,000 -116,000,000 -478,000,000 -102,000,000
Operating Cash Flow 1,751,000,000 1,772,000,000 1,312,000,000 1,485,000,000
Investing Activities
Capital Expenditure -378,000,000 -298,000,000 -291,000,000 -189,000,000
Investments -378,000,000 -298,000,000 -291,000,000 -188,000,000
Investing Cash Flow -1,258,000,000 -310,000,000 -338,000,000 -749,000,000
Financing Activities
Debt Repayment 637,000,000 -35,000,000 -1,869,000,000 -2,139,000,000
Common Stock Issued/Repurchased -1,150,000,000 -575,000,000 -1,081,000,000 -788,000,000
Dividends Paid -274,000,000 -265,000,000 -250,000,000 -236,000,000
Financing Cash Flow -752,000,000 -930,000,000 -1,372,000,000 -696,000,000
Summary
Free Cash Flow 1,373,000,000 1,474,000,000 1,021,000,000 1,296,000,000
Net Change in Cash -261,000,000 537,000,000 -434,000,000 43,000,000
Cash Flow Statement (Annual) 2024-10-31 2023-10-31 2022-10-31 2021-10-31 2020-10-31
Operating Activities
Net Income 1,289,000,000 1,240,000,000 1,254,000,000 1,210,000,000 719,000,000
Depreciation & Amortization 257,000,000 271,000,000 317,000,000 321,000,000 308,000,000
Stock Based Compensation 129,000,000 111,000,000 125,000,000 110,000,000 83,000,000
Change in Working Capital 83,000,000 -116,000,000 -478,000,000 -102,000,000 -325,000,000
Operating Cash Flow 1,751,000,000 1,772,000,000 1,312,000,000 1,485,000,000 921,000,000
Investing Activities
Capital Expenditure -378,000,000 -298,000,000 -291,000,000 -189,000,000 -119,000,000
Investments -378,000,000 -298,000,000 -291,000,000 -188,000,000 -119,000,000
Investing Cash Flow -1,258,000,000 -310,000,000 -338,000,000 -749,000,000 -147,000,000
Financing Activities
Debt Repayment 637,000,000 -35,000,000 -1,869,000,000 -2,139,000,000 -1,762,000,000
Common Stock Issued/Repurchased -1,150,000,000 -575,000,000 -1,081,000,000 -788,000,000 -409,000,000
Dividends Paid -274,000,000 -265,000,000 -250,000,000 -236,000,000 -222,000,000
Financing Cash Flow -752,000,000 -930,000,000 -1,372,000,000 -696,000,000 -717,000,000
Summary
Free Cash Flow 1,373,000,000 1,474,000,000 1,021,000,000 1,296,000,000 802,000,000
Net Change in Cash -261,000,000 537,000,000 -434,000,000 43,000,000 59,000,000